Cargando…

A systematic review of adverse drug events associated with administration of common asthma medications in children

OBJECTIVE: To systematically review the literature and determine frequencies of adverse drug events (ADE) associated with pediatric asthma medications. METHODS: Following PRISMA guidelines, we systematically searched six bibliographic databases between January 1991 and January 2017. Study eligibilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, James S., Johnson, David W., Sperou, Arissa J., Crotts, Jennifer, Saude, Erik, Hartling, Lisa, Stang, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549998/ https://www.ncbi.nlm.nih.gov/pubmed/28793336 http://dx.doi.org/10.1371/journal.pone.0182738

Ejemplares similares

Adverse Events Related to Emergency Department Care: A Systematic Review
por: Stang, Antonia S., et al.
Publicado: (2013)

Adverse Drug Events Related to Common Asthma Medications in US Hospitalized Children, 2000–2016
por: Xie, Luyu, et al.
Publicado: (2022)

Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation
por: Robb, Kevin P., et al.
Publicado: (2017)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Reporting adverse drug events to the Therapeutic Goods Administration
por: Martin, Jennifer H, et al.
Publicado: (2021)

Quality indicators for the assessment and management of pain in the emergency department: A systematic review
por: Stang, Antonia S, et al.
Publicado: (2014)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia
por: Cotechini, Tiziana, et al.
Publicado: (2014)

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives
por: Polepalli Ramesh, Balaji, et al.
Publicado: (2014)

How Safe Are Common Analgesics for the Treatment of Acute Pain for Children? A Systematic Review
por: Hartling, Lisa, et al.
Publicado: (2016)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
por: Bai, Xiaoyin, et al.
Publicado: (2021)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
por: Learned, Christine, et al.
Publicado: (2022)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs
por: Rydberg, Diana M, et al.
Publicado: (2018)

Adverse events in the paediatric emergency department: a prospective cohort study
por: Plint, Amy C, et al.
Publicado: (2021)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Quality of reporting in systematic reviews of adverse events: systematic review
por: Zorzela, Liliane, et al.
Publicado: (2014)

Commonality of Drug-associated Adverse Events Detected by 4 Commonly Used Data Mining Algorithms
por: Sakaeda, Toshiyuki, et al.
Publicado: (2014)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

ICD-10 codes used to identify adverse drug events in administrative data: a systematic review
por: Hohl, Corinne M, et al.
Publicado: (2014)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

S5. DOES THE TIME OF DRUG ADMINISTRATION ALTER THE ADVERSE EVENT RISK OF LURASIDONE?
por: Hagi, Katsuhiko, et al.
Publicado: (2020)

Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study
por: Hohl, Corinne M, et al.
Publicado: (2013)

Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration
por: Chen, Wenxin, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events
por: Kottschade, Lisa
Publicado: (2021)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting
por: Serebruany, Victor L., et al.
Publicado: (2017)

A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19()
por: Patel, Purva, et al.
Publicado: (2023)

The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System
por: Raschi, Emanuel, et al.
Publicado: (2022)

Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system
por: Wang, Jun, et al.
Publicado: (2023)

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
por: Naganuma, Misa, et al.
Publicado: (2019)

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
por: Wei, Shaokui, et al.
Publicado: (2021)

Preventing Medication Errors and Adverse Drug Events
por: Curtiss, Frederic R.
Publicado: (2003)

Adverse drug events in pediatric intensive care are common, but improvement strategies exist and are effective
por: Allegaert, Karel
Publicado: (2016)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis
por: Zhou, Zeyun, et al.
Publicado: (2020)

Neurological adverse events following regional anesthesia administration
por: Kent, Christopher D, et al.
Publicado: (2010)

271 Evaluation of Adverse Events Associated to Administration of Omalizumab
por: Gomez, R. Maximiliano, et al.
Publicado: (2012)

Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
por: Wang, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7tref83qh5ko7rapph5mdfteqq